Exicure just dropped some wild results from their blood cancer trial—nearly 90% of patients hit the main goal, and their new drug combo works crazy fast. The stock shot up over 60% in a day! Even patients who’d tried tough treatments before saw big wins. Plus, hardly any side effects. This could totally shake up how stem cells are collected for transplants. Biotech fans, keep your eyes on this one! #Health #BodyHealth #biotech